Just weeks after activist investor Carl Icahn acquired a major stake in Bedford’s Hologic Inc., the company has replaced its chief executive officer and appointed two new board members.
The maker of medical diagnostic and imaging equipment named Stephen MacMillan to head the company, replacing former CEO Jack Cumming. He was at the helm of the troubled company only since July. MacMillian previously headed up Stryker Corp.
New board members Jonathan Christodoro and Samuel Merksamer are Icahn appointees. “As members of the Board, Jonathan and Sam will work with the other directors and the management team to enhance the value of the Company for all shareholders. Our record shows that our involvement on boards has often created meaningful value for all shareholders. We hope this will continue with Hologic,” Icahn said in a statement.
Icahn announced his 12.63 percent stake in Hologic last month and at the time said he would agitate for a change in management.
On Monday, Icahn endorsed the changes with this tweet: